stockrowPerrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.
- Revenue
- −5.24%
- EPS
- −494.6%
- Free cash flow
- +138.5%
- Total debt
- −9.62%
Quarter to September 2026, against a year earlier
Follow PRGO
Alert me
Perrigo Company plc (PRGO) Total debt
Perrigo Company plc's total debt at the end of fiscal 2025 was $3.6B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $3.3B. Over the past ten years it has ranged from $3.2B (fiscal 2018) to $6.0B (fiscal 2015); the current reading is higher than 58% of that period. Perrigo Company plc ranks 6th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $3.6B | 0.61% |
| FY2024 | $3.6B | (11.18%) |
| FY2023 | $4.1B | (0.81%) |
| FY2022 | $4.1B | 16.65% |
| FY2021 | $3.5B | (1.25%) |
| FY2020 | $3.6B | 5.81% |
| FY2019 | $3.4B | 3.91% |
| FY2018 | $3.2B | (2.96%) |
| FY2017 | $3.3B | (42.37%) |
| FY2016 | $5.8B | (3.89%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $3.3B | (0.02%) |
| Jun 2026 | $3.3B | (9.30%) |
| Mar 2026 | $3.6B | (0.21%) |
| Dec 2025 | $3.6B | (0.12%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| PRGO Perrigo Company plc | $3.3B |
| PBH Prestige Consumer Healthcare Inc. compare | $2.0B |
| ALVO Alvotech compare | $1.3B |
| BCRX BioCryst Pharmaceuticals, Inc. compare | $839.4M |
| TRLV Trulieve Cannabis Corp. compare | $345.0M |
| XERS Xeris Biopharma Holdings, Inc. compare | $189.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $94.5M |
| ANIP ANI Pharmaceuticals, Inc. compare | $23.4M |
| RGC Regencell Bioscience Holdings Limited compare | $463.7K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on PRGO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement